Literature DB >> 28571237

Dexmedetomidine as an Additive to Spinal Anaesthesia in Orthopaedic Patients Undergoing Lower Limb Surgeries: A Randomized Clinical Trial Comparing Two Different Doses of Dexmedetomidine.

Arati Rai1, Meyong Pincho Bhutia1.   

Abstract

INTRODUCTION: Use of dexmedetomidine as an additive to spinal anaesthesia is gaining popularity; but there seems to be no clear consensus on the ideal dose to be used. Because of dose related prolongation of duration of motor blockade along with increase in the incidence of side effects of dexmedetomidine namely hypotension and bradycardia, use of higher doses is not recommended. AIM: To evaluate the efficacy of two different doses of dexmedetomidine (3 μg and 5 μg) given in combination with 0.5% hyperbaric bupivacaine via intrathecal route with regard to the quality of anaesthesia namely the time to attain highest sensory and motor blockade, side effects of dexmedetomidine and time to first rescue analgesia.
MATERIALS AND METHODS: Sixty American Society of Anaesthesiologist (ASA) Grade I and II orthopaedic patients undergoing lower limb surgeries between the ages of 20-60 years and height >150 cm were randomly divided into two groups of 30 patients each: Group D3 to receive 3 μg of Inj. Dexmedetomidine (0.5 ml, reconstituted using normal saline) along with 12.5 mg (2.5 ml) of 0.5% hyperbaric bupivacaine and Group D5 to receive 5 μg of inj. Dexmedetomidine (0.5 ml, reconstituted using normal saline) along with 12.5 mg (2.5 ml) of 0.5% hyperbaric bupivacaine keeping the total volume of study drug constant in all 60 patients (3 ml). Data recordings were done for time to reach best sensory and motor block, intraoperative haemodynamic changes and time to first postoperative rescue analgesia. Statistical analysis was done using student's t-test and Chi-square test with p-value of <0.05 considered to be significant.
RESULTS: The two groups analysed were similar in terms of demographic profile, time to reach highest sensory block (T10) dermatome, time to reach Bromage scale 4, time to surgical incision after spinal and the total duration of surgery (p>0.05). The change in haemodynamics was similar (p>0.05). A statistically significant difference (p<0.001) was observed in time to first rescue analgesia after skin closure with Group D3 having 206.47 minutes while in Group D5 the time was 271.33 minutes.
CONCLUSION: Used in a dose of 5 μg (in 0.5 ml volume) as an additive in spinal anaesthesia maximal beneficial effect of dexmedetomidine can be obtained without any side effects.

Entities:  

Keywords:  Bromage scale; Lumbar puncture; Motor blockade; Postoperative rescue analgesia

Year:  2017        PMID: 28571237      PMCID: PMC5449883          DOI: 10.7860/JCDR/2017/26241.9654

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  The post-anesthesia recovery score revisited.

Authors:  J A Aldrete
Journal:  J Clin Anesth       Date:  1995-02       Impact factor: 9.452

2.  Intrathecal midazolam increases the analgesic effects of spinal blockade with bupivacaine in patients undergoing haemorrhoidectomy.

Authors:  M H Kim; Y M Lee
Journal:  Br J Anaesth       Date:  2001-01       Impact factor: 9.166

3.  Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine.

Authors:  P Talke; C A Richardson; M Scheinin; D M Fisher
Journal:  Anesth Analg       Date:  1997-11       Impact factor: 5.108

Review 4.  Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates.

Authors:  M T Piascik; E E Soltis; M M Piascik; L B Macmillan
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

Review 5.  Opioid complications and side effects.

Authors:  Ramsin Benyamin; Andrea M Trescot; Sukdeb Datta; Ricardo Buenaventura; Rajive Adlaka; Nalini Sehgal; Scott E Glaser; Ricardo Vallejo
Journal:  Pain Physician       Date:  2008-03       Impact factor: 4.965

6.  Dexmedetomidine as an intrathecal adjuvant for postoperative analgesia.

Authors:  Rajni Gupta; Jaishri Bogra; Reetu Verma; Monica Kohli; Jitendra Kumar Kushwaha; Sanjiv Kumar
Journal:  Indian J Anaesth       Date:  2011-07

7.  A Comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine.

Authors:  Rajni Gupta; Reetu Verma; Jaishri Bogra; Monica Kohli; Rajesh Raman; Jitendra Kumar Kushwaha
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

8.  Dexmedetomidine: New avenues.

Authors:  Anju Grewal
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

9.  A prospective randomised double blind study of intrathecal fentanyl and dexmedetomidine added to low dose bupivacaine for spinal anesthesia for lower abdominal surgeries.

Authors:  Hem Anand Nayagam; N Ratan Singh; H Shanti Singh
Journal:  Indian J Anaesth       Date:  2014-07

10.  Comparative study of two doses of intrathecal dexmedetomidine as adjuvant with low dose hyperbaric bupivacaine in ambulatory perianal surgeries: A prospective randomised controlled study.

Authors:  K Sudheesh; Rs Raghavendra Rao; M Kavya; J Aarthi; D Devika Rani; S S Nethra
Journal:  Indian J Anaesth       Date:  2015-10
  10 in total
  2 in total

1.  Efficacy of premixed versus succedent administration of fentanyl and bupivacaine in subarachnoid block for lower limb surgeries: A randomised control trial.

Authors:  Aaina Malhotra; Udeyana Singh; M Rupinder Singh; Dinesh Sood; Anju Grewal; Anuj Mahajan
Journal:  Indian J Anaesth       Date:  2020-08-15

2.  Comparison of Morphine and Dexmedetomidine as Adjuvants to Isobaric Levobupivacaine for Spinal Anesthesia in Patients Undergoing Abdominal Hysterectomy.

Authors:  Mamta Sinha; Mayank Kumar; Ishaan Dubey; Subrat Kumar Singha; Habib Md Reazaul Karim; Khushbu Karoo
Journal:  Anesth Essays Res       Date:  2021-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.